Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.38 -0.13 (-2.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Verrica Pharmaceuticals (VRCA) Short-term Investments (2018)

Updated

Verrica Pharmaceuticals' Short-term Investments came in at $79.54 million for Q4 2018, up 35.6% from the prior quarter.

Analysis

Verrica Pharmaceuticals (VRCA) Short-term Investments (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Verrica Pharmaceuticals 77.48 Mn -5.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 79.54 Mn
Sep 30, 2018 58.66 Mn
API Access

Verrica Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=VRCA&period=max&api_key=YOUR_API_KEY